HeartSciences Inc. Files Form 8-K Announcing Amended Merger Agreement with Fortitude Mining Holdings, Inc.
HeartSciences Inc. (NASDAQ: HSCS) has filed a Form 8-K with the U.S. Securities and Exchange Commission (SEC) on July 27, 2026, disclosing significant updates regarding its pending merger with Fortitude Mining Holdings, Inc. The filing contains key information that shareholders and potential investors should closely consider, as it may have material impacts on the company’s strategic direction and share value.
Key Highlights from the 8-K Filing
- Filing Type: Current Report on Form 8-K
- Date of Report: July 27, 2026
- Registrant: HeartSciences Inc.
- Trading Symbols: Common Stock (HSCS), Warrants (HSCSW)
- Exchange: NASDAQ Stock Market LLC for both Common Stock and Warrants
- Merger Update: The report describes an amendment to the previously announced merger agreement with Fortitude Mining Holdings, Inc.
- Soliciting Material: The filing is flagged as containing soliciting material under SEC rules, signifying its use in seeking proxy votes or shareholder approvals for the transaction.
- Emerging Growth Company: HeartSciences confirms its status as an “emerging growth company” under the federal securities laws.
Details of the Amended Merger Agreement
HeartSciences has entered into an amendment to the original merger agreement with Fortitude Mining Holdings, Inc. The details of both the amendment and the original agreement are incorporated by reference in the 8-K filing, and the amendment is attached as Exhibit 2.1 to the current report.
While the filing itself does not disclose every term of the amended agreement, it clarifies that the amendment and the original merger agreement together govern the terms of the proposed transaction. The original merger agreement had previously been filed with the SEC on June 23, 2026. Investors are encouraged to review both documents for a full understanding of the deal’s structure.
Implications for Shareholders
- Proxy Statement to be Filed: HeartSciences will file a proxy statement with the SEC, which will include details of the transactions contemplated by the amended merger agreement. Shareholders will receive this proxy statement and will be asked to approve the merger and related matters at a forthcoming special meeting.
- Solicitation of Proxies: Directors and executive officers of HeartSciences, Fortitude, and certain related parties, may be considered “participants” in the solicitation of proxies from HeartSciences shareholders. Information about these individuals and their interests will be included in the proxy statement and other SEC filings.
- No Offer or Sale of Securities Yet: The filing explicitly states that it is not a proxy statement, nor is it an offer to sell or exchange any securities. Any sale or exchange of securities will only occur through a registered prospectus or a valid exemption.
Important Note for Investors
Regulatory Approvals: Neither the SEC nor any state securities regulator has approved or disapproved the transactions described in the filing, nor have they judged the merits or fairness of the proposed merger. Any representation to the contrary is a criminal offense.
Potential Price-Sensitive Information
- Merger Progress: The movement towards an amended and restated merger agreement with Fortitude Mining Holdings, Inc. is a material event that could affect HeartSciences’ strategic outlook and valuation.
- Proxy Vote and Shareholder Approval: The requirement for a special meeting and shareholder vote introduces uncertainty and the potential for significant share price movement, depending on the outcome of the vote and the final terms of the merger.
- Emerging Growth Company Status: HeartSciences’ confirmation as an emerging growth company may influence investor expectations regarding regulatory compliance, financial reporting, and growth prospects.
- Soliciting Material Disclosure: Because the filing is flagged as soliciting material, it is part of the formal process to secure shareholder support for the merger, which is a critical step for the deal’s completion.
Next Steps and Additional Information
HeartSciences will distribute the definitive proxy statement to shareholders as of a record date to be set. Investors should read the proxy statement (including any amendments or supplements) and all other relevant documents filed with the SEC before making any voting or investment decisions regarding the merger.
All documents will be available free of charge on the SEC’s website at www.sec.gov once filed.
Conclusion
The announcement of an amended merger agreement between HeartSciences Inc. and Fortitude Mining Holdings, Inc. is a significant corporate development. The transaction’s completion will depend on regulatory filings, shareholder approval, and the terms disclosed in the forthcoming proxy statement. Investors should monitor future filings for additional details and consider the potential impacts on HeartSciences’ share value.
Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should consult the official SEC filings and their own financial advisors before making any investment decisions. The information herein is current as of the date of the SEC filing and may be subject to change.
